News | Neuronos

top of page

News

Find out the latest news and updates

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

March 24, 2025

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

November 26, 2024

Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)

August 07, 2023

Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem

June 15, 2023

The NO Answer for Autism Spectrum Disorder

M. K. Tripathi, S. K. Ojha, M. Kartawy, W. Hamoudi, A. Choudhary, S. Stern, A. Aran, H. Amal (2023), June 2023

The Role of Thioredoxin System in Shank3 Mouse Model of Autism

Bazbaz W. et al. Journal of Molecular Neuroscience, 2024

Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism

Amal H. et al. (2023), September 2023

A cross-talk between nitric oxide and the glutamatergic system in a Shank3 mouse model of autism

Hamoudi W. et al. Free Radical Biology and Medicine, 2022

Arsenic alters nitric oxide signaling similar to autism spectrum disorder and Alzheimer's disease-associated mutations

Tripathi M. et al. Translational Psychiatry, 2022

Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway

Mencer S. et al. Translational psychiatry, 2021

*All publications were published by Prof. Amal's academic research staff

bottom of page